Finance

Lists
600223:SHA
Lushang Freda Pharmaceutical Co Ltd
CN¥5.61
-0.36%
(-0.020) 1D
Oct 16, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600223...
Open
CN¥5.70
High
CN¥5.76
Low
CN¥5.57
Mkt. cap
5.70B
Avg. vol.
7.60M
Volume
7.69M
Dividend
1.02%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 15, 2026
P/E ratio
35.30
52-wk high
CN¥8.37
52-wk low
CN¥4.89
EPS
CN¥0.16
Shares outstanding
1.00B
No. of employees
4K
Open
CN¥5.70
High
CN¥5.76
Low
CN¥5.57
Mkt. cap
5.70B
Avg. vol.
7.60M
Volume
7.69M
Dividend
1.02%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 15, 2026
P/E ratio
35.30
52-wk high
CN¥8.37
52-wk low
CN¥4.89
EPS
CN¥0.16
Shares outstanding
1.00B
No. of employees
4K
News stories
From web sources and news partners
About Lushang Freda Pharmaceutical Co Ltd
CEO-
Employees3.51K
FoundedApr 21, 1993
Headquarters-
SectorPersonal care products
Websitelshfreda.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
807.27M
1.05B
900.44M
1.01B
Cost of goods sold
405.63M
471.27M
396.42M
421.75M
Cost of revenue
405.63M
471.27M
396.42M
421.75M
Research and development expenses
36.89M
45.66M
36.86M
48.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
341.03M
474.78M
430.50M
473.99M
Operating expense
374.09M
533.36M
480.80M
539.54M
Total operating expenses
779.72M
1.00B
877.22M
961.29M
Operating income
27.55M
49.45M
23.22M
47.58M
Other non operating income
1.07M
-957.33K
-791.85K
-5.62M
EBT including unusual items
48.93M
82.80M
43.83M
72.63M
EBT excluding unusual items
57.55M
64.40M
43.79M
64.06M
Income tax expense
4.84M
23.67M
6.31M
8.27M
Effective tax rate
9.90%
28.59%
14.40%
11.39%
Other operating expenses
-7.23M
19.88M
5.68M
11.18M
Net income
33.78M
46.01M
31.90M
49.88M
Net profit margin
4.18%
4.36%
3.54%
4.94%
Earnings per share
-
-
-
-
Interest and investment income
29.41M
17.70M
21.99M
23.61M
Interest expense
-
-2.08M
-629.37K
-711.25K
Net interest expenses
29.41M
15.63M
21.36M
22.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
50.97M
75.36M
49.13M
73.66M
Gain or loss from assets sale
37.48K
55.90K
-
-78.27K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps